|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chang ET and Adami HO: The enigmatic
epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 15:1765–1777. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
ONeil JD, Owen TJ, Wood VH, Date KL,
Valentine R, Chukwuma MB, Arrand JR, Dawson CW and Young LS:
Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription
factor pathway in nasopharyngeal carcinoma cells and enhances
angiogenesis in vitro. J Gen Virol. 89:2833–2842. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Strange RC, Spiteri MA, Ramachandran S and
Fryer AA: Glutathione-S-transferase family of enzymes. Mutat Res.
482:21–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oakley A: Glutathione transferases: A
structural perspective. Drug Metab Rev. 43:138–151. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayes JD and Strange RC: Glutathione
S-transferase polymorphisms and their biological consequences.
Pharmacology. 61:154–166. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX,
Song Y, Xu X and Ma J: Glutathione S-transferase M1 (GSTM1) and
glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking,
and their interaction in oral cancer: A HuGE review and
meta-analysis. Am J Epidemiol. 173:847–857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Taioli E, Flores-Obando RE, Agalliu I,
Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S,
Lavender NA, et al: Multi-institutional prostate cancer study of
genetic susceptibility in populations of African descent.
Carcinogenesis. 32:1361–1365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nazar-Stewart V, Vaughan TL, Burt RD, Chen
C, Berwick M and Swanson GM: Glutathione S-transferase M1 and
susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol
Biomarkers Prev. 8:547–551. 1999.PubMed/NCBI
|
|
10
|
Guo XL: Genetic polymorphism of cytochrome
P450 1A1 and glutathione S-transferase Ml related with
susceptibility of nasopharyngeal carcinoma. Hebei Med Univ.
2001.
|
|
11
|
Da SJ, Liang B, Wu HL and Guan LL:
Relationship between GSTM1 gene polymorphism and genetic
susceptibility in nasopharyngeal carcinoma. Prac J of Cancer.
17:617–619. 2002.(In Chinese).
|
|
12
|
Cheng YJ, Chien YC, Hildesheim A, Hsu MM,
Chen IH, Chuang J, Chang J, Ma YD, Luo CT, Hsu WL, et al: No
association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1,
GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer
Epidemiol Biomarkers Prev. 12:179–180. 2003.PubMed/NCBI
|
|
13
|
Liu ZG, Wei YP and Ma Y: Population with
GSTT1 gene deletion and the relationship to hepatocellular
carcinoma from Guangxi. J Guangxi Med Univ. 20:161–163. 2003.(In
Chinese).
|
|
14
|
Deng ZL, Wei YP and Ma Y: Frequent genetic
deletion of detoxifying enzyme GSTM1 and GSTT1 genes in
nasopharyngeal carcinoma patients in Guangxi Province, China.
Zhonghua Zhong Liu Za Zhi. 26:598–600. 2004.(In Chinese).
PubMed/NCBI
|
|
15
|
Deng ZL, Wei YP, Luo W, Liao ZL and Ma Y:
Glutathione S-transferase M1 and T1 gene deletion associated with
increased susceptibility to nasopharyngeal carcinoma.
Chinese-German J Clin Oncol. 4:276–278. 2005. View Article : Google Scholar
|
|
16
|
Tiwawech D, Srivatanakul P, Karalak A and
Ishida T: Glutathione S-transferase M1 gene polymorphism in Thai
nasopharyngeal carcinoma. Asian Pac J Cancer Prev. 6:270–275.
2005.PubMed/NCBI
|
|
17
|
Bendjemana K, Abdennebi M, Gara S, Jmal A,
Ghanem A, Touati S, Boussen H, Ladgham A and Guemira F: Genetic
polymorphism of gluthation-S transferases and N-acetyl transferases
2 and nasopharyngeal carcinoma: The Tunisia experience. Bull
Cancer. 93:297–302. 2006.PubMed/NCBI
|
|
18
|
Guo X, OBrien SJ, Zeng Y, Nelson GW and
Winkler CA: GSTM1 and GSTT1 gene deletions and the risk for
nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol
Biomarkers Prev. 17:1760–1763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He Y, Zhou GQ, Li X, Dong XJ, Chai XQ and
Yao KT: Correlation of polymorphism of the coding region of
glutathione S-transferase M1 to susceptibility of nasopharyngeal
carcinoma in South China population. Ai Zheng. 28:5–7. 2009.(In
Chinese). PubMed/NCBI
|
|
20
|
Jiang Y, Li N, Dong P, Zhang N, Sun Y, Han
M, Wen J and Chen M: Polymorphisms in GSTM1, GSTTI and GSTP1 and
nasopharyngeal cancer in the East of China: a case-control study.
Asian Pacif J Cancer Prev. 12:3097–3100. 2011.
|
|
21
|
Wei YP, Long XD, Liu ZG, Ma Ya and Deng
ZL: Genetic polymorphism of glutathione-S-transferase M1 and T1 in
associated with carcinogenesis of hepatocellular carcinoma and
nasopharyngeal carcinoma. Chinese-German J Clin Oncol. 11:138–141.
2012. View Article : Google Scholar
|
|
22
|
Liao ZL, Deng ZL, Wei YP, Xie KS, Zhang B,
Dai XM and Xu CS: Relationship of GSTT1 and GSTM1 gene
polymorphisms with the development of nasopharyngeal carcinoma. J
Guangxi Med Univ. 22:372–374. 2005.
|
|
23
|
Tian SZ: The analysis of clinical factors
related to laryngeal carcinoma and research on the association
between genetic polymorphisms of xenobiotic-metabolizing enzymes.
DNA repair genes and susceptibility to laryngeal carcinoma
(Zhongshan Univ). 2001.
|
|
24
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
26
|
Cochran WG: The comparison of percentages
in matched samples. Biometrika. 37:256–266. 1950. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Stuck AE, Rubenstein LZ and Wieland D:
Bias in meta-analysis detected by a simple, graphical test:
Asymmetry detected in funnel plot was probably due to true
heterogeneity. BMJ. 316:469–471. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tobias A, Saez M, Galan I and Campbell MJ:
Sensitivity analysis of common statistical models used to study the
short-term effects of air pollution on health. Int J Biometeorol.
47:227–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayes JD, Flanagan JU and Jowsey IR:
Glutathione transferases. Annu Rev Pharmacol Toxicol. 45:51–88.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sharma R, Yang Y, Sharma A, Awasthi S and
Awasthi YC: Antioxidant role of glutathione S-transferases:
Protection against oxidant toxicity and regulation of
stress-mediated apoptosis. Antioxid Redox Signal. 6:289–300. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Strange RC, Lear JT and Fryer AA:
Glutathione S-transferase polymorphisms: Influence on
susceptibility to cancer. Chem Biol Interact. 111(112): 351–364.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moaven O, Raziee HR, Sima HR, Ganji A,
Malekzadeh R, A'Rabi A, Abdollahi A, Memar B, Sotoudeh M, Naseh H,
et al: Interactions between glutathione-S-transferase M1, T1 and P1
polymorphisms and smoking, and increased susceptibility to
esophageal squamous cell carcinoma. Cancer Epidemiol. 34:285–290.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karami S, Boffetta P, Rothman N, Hung RJ,
Stewart T, Zaridze D, Navritalova M, Mates D, Janout V, Kollarova
H, et al: Renal cell carcinoma, occupational pesticide exposure and
modification by glutathione S-transferase polymorphisms.
Carcinogenesis. 29:1567–1571. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sreeja L, Syamala V, Hariharan S, Syamala
VS, Raveendran B, Sivanandan CD, Madhavan J and Ankathil R:
Glutathione S-transferase M1, T1 and P1 polymorphisms:
Susceptibility and outcome in lung cancer patients. J Exp Ther
Oncol. 7:73–85. 2008.PubMed/NCBI
|
